What is the LZAX Immunization Study for Alzheimer's Disease?
The LZAX study is designed to test the long-term safety and efficacy of solanezumab in patients with mild Alzheimer's Disease.
What is the Purpose of LZAX?
This study is assessing if LZAX will slow the cognitive and functional decline of Alzheimer's disease (AD) as compared with placebo in patients with mild AD.
Eligible patients will be males & females between the ages of 50-90 yrs old with mild Alzheimer's Disease. Additional study criteria will be reviewed with patient and caregiver prior to enrolling into study
If you are interested in learning more about the LZAX study, please call (401) 455-6403 or send an e-mail to: email@example.com.
More information on other current research studies at Butler Hospital.